Diagnose and treat constipation- or diarrhoea-predominant irritable bowel syndrome with confidence

被引：0
|
作者：
Fenton, Caroline [1 ]
Kang, Connie [1 ]
机构：
[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
来源：
DRUGS & THERAPY PERSPECTIVES | 2022年 / 38卷 / 04期
关键词：
MANAGEMENT; GUIDELINE;
D O I：
10.1007/s40267-022-00906-w
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Irritable bowel syndrome (IBS) is diagnosed based on clinical criteria of regular abdominal pain and disordered defaecation. If first-line treatments such as lifestyle changes fail, patients with diarrhoea-predominant IBS may respond to rifaximin, eluxadoline or, for women, alosetron, if tolerated. For constipation-predominant IBS, options are tegaserod for younger women, and the secretagogues linaclotide, plecanatide, lubiprostone and tenapanor. As IBS is a gut-brain interaction disorder, neuromodulators such as tricyclic antidepressants may help.
引用
收藏
页码：171 / 176
页数：6
相关论文
共 50 条
  • [11] Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome
    Barbara, Giovanni
    Cremon, Cesare
    GUT, 2008, 57 (08) : 1035 - 1037
  • [12] Methane and Constipation- predominant Irritable Bowel Syndrome: Entwining Pillars of Emerging Neurogastroenterology
    Bin Waqar, Syed Hamza
    Rehan, Aiman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (05)
  • [13] Entero-endocrine cells are elevated in diarrhoea-predominant irritable bowel syndrome
    Dunlop, SP
    Wyke, H
    Jenkins, D
    Spiller, RC
    GASTROENTEROLOGY, 2001, 120 (05) : A751 - A751
  • [14] Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
    Vahedi, H.
    Merat, S.
    Momtahen, S.
    Kazzazi, A. S.
    Ghaffari, N.
    Olfati, G.
    Malekzadeh, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (08) : 678 - 684
  • [15] Bile acid malabsorption and ileal histology in diarrhoea-predominant irritable bowel syndrome
    Srinivas, M.
    Basumani, P.
    Dawson, B.
    Smith, M. J.
    Lee, J. A.
    Bardhan, K. D.
    GUT, 2007, 56 : A29 - A30
  • [16] Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
    Zhu, Lingping
    Ma, Yunhui
    Ye, Shasha
    Shu, Zhiqun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [17] Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome
    Lu, CL
    Chen, CY
    Chang, FY
    Chang, SS
    Kang, LJ
    Lu, RH
    Lee, SD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (08) : 925 - 930
  • [18] Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome
    Wang Jun-ping
    Hou Xiao-hua
    CHINESE MEDICAL JOURNAL, 2007, 120 (04) : 313 - 316
  • [19] Diarrhoea-predominant irritable bowel syndrome colonic biopsies exhibit tuft cell hyperplasia
    Connolly, M.
    Aigbologa, J.
    O'Brien, R.
    Buckley, M. M.
    Buckley, J. M.
    O'Malley, D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [20] Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome
    Camilleri, M.
    Acosta, A.
    Busciglio, I.
    Boldingh, A.
    Dyer, R. B.
    Zinsmeister, A. R.
    Lueke, A.
    Gray, A.
    Donato, L. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 438 - 448
12345